Darren Schmidt, Abdulla Salahudeen
Journal: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition 2007;22(1):11-5
PMID: 17242449
Obesity is increasingly common in the United States, and it frequently coexists with diabetes and hypertension. Given that diabetes and hypertension are the 2 most common causes of end-stage renal disease, it is not surprising that obesity is also highly prevalent in the US hemodialysis population. However, unlike in the general population, obesity is associated with improved survival in hemodialysis patients. This phenomenon, the obesity-survival paradox, is neither universally accepted nor completely understood. In this article, we review the available data and provide potential reasons for the obesity-survival paradox in the dialysis population.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.